Fundraising FoxSiduma Therapeutics
New Haven, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Siduma Therapeutics
Sign up to see every warm intro you have to Siduma Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Siduma Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CC
Craig CrewsNamed on SEC filing
RF
Rebecca FreyNamed on SEC filing
TS
Timothy ShannonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$31.2M disclosed across 1 round · 2021
▶$31.2MraisedNov 2021 · 11 investors · BiotechnologyRule 506(b)
▶$31.2MraisedNov 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig CrewsExecutive Officer, Director
- Rebecca FreyDirector
- Timothy ShannonDirector
- Offering amount
- $31.2M
- Amount sold
- $31.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Siduma Therapeutics's investors?
- Siduma Therapeutics's investors include Elm Street Ventures.
- How much funding has Siduma Therapeutics raised?
- Siduma Therapeutics has disclosed $31.2M raised across 1 round.
- Where is Siduma Therapeutics headquartered?
- Siduma Therapeutics is headquartered in New Haven, US.